chr17-28489340-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003984.4(SLC13A2):c.229G>A(p.Glu77Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000177 in 1,585,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003984.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC13A2 | NM_003984.4 | c.229G>A | p.Glu77Lys | missense_variant, splice_region_variant | 2/12 | ENST00000314669.10 | NP_003975.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC13A2 | ENST00000314669.10 | c.229G>A | p.Glu77Lys | missense_variant, splice_region_variant | 2/12 | 1 | NM_003984.4 | ENSP00000316202.6 |
Frequencies
GnomAD3 genomes AF: 0.0000321 AC: 4AN: 124710Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000877 AC: 2AN: 227946Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 123650
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461276Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726934
GnomAD4 genome AF: 0.0000321 AC: 4AN: 124710Hom.: 0 Cov.: 33 AF XY: 0.0000329 AC XY: 2AN XY: 60714
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.229G>A (p.E77K) alteration is located in exon 2 (coding exon 2) of the SLC13A2 gene. This alteration results from a G to A substitution at nucleotide position 229, causing the glutamic acid (E) at amino acid position 77 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at